Genetic Technologies' Digital Strategy Ignites Significant Traction In US Market
Portfolio Pulse from Benzinga Newsdesk
Genetic Technologies Limited (NASDAQ:GENE) reports significant positive impact from its new digital strategy on social media engagement and consumer reach, predicting a surge in the adoption of risk assessment tests. This strategy, led by Dr. Malcolm Bohm, has resulted in increased interactions, engagement, and website traffic, indicating growing interest in genomics-based health and wellness tests. The company's approach is contributing to a shift towards proactive healthcare, with an increasing number of healthcare professionals in the US and Australia referring patients to GTG's services.
April 02, 2024 | 12:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Genetic Technologies Limited's new digital strategy has significantly increased social media engagement and consumer reach, indicating a potential surge in the adoption of its genomics-based tests.
The reported increases in consumer reach, content interactions, engagement, and website traffic directly relate to Genetic Technologies' efforts to enhance its digital presence. This strategy not only boosts the company's visibility but also potentially increases the adoption of its genomics-based tests, which could lead to higher revenues. The positive feedback from healthcare professionals and the growing clinician referral base in the US and Australia further support the potential for increased demand for GTG's services.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100